HK Stock MarketDetailed Quotes

01931 IVD MEDICAL

Watchlist
  • 2.270
  • -0.020-0.87%
Market Closed Apr 25 16:09 CST
3.07BMarket Cap11.70P/E (TTM)

IVD MEDICAL Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Turnover
12.35%3.09B
17.06%1.38B
0.66%2.75B
-0.86%1.18B
12.46%2.73B
20.95%1.19B
4.09%2.43B
7.50%981.24M
463.96%2.33B
--912.76M
Operating income
12.35%3.09B
17.06%1.38B
0.66%2.75B
-0.86%1.18B
12.46%2.73B
20.95%1.19B
4.09%2.43B
7.50%981.24M
463.96%2.33B
912.76M
Cost of sales
-12.89%-2.42B
-18.20%-1.08B
1.10%-2.14B
3.88%-910.13M
-10.88%-2.16B
-20.31%-946.9M
-3.29%-1.95B
-12.82%-787.06M
-536.39%-1.89B
---697.6M
Operating expenses
-12.89%-2.42B
-18.20%-1.08B
1.10%-2.14B
3.88%-910.13M
-10.88%-2.16B
-20.31%-946.9M
-3.29%-1.95B
-12.82%-787.06M
-536.39%-1.89B
-697.6M
Gross profit
10.45%671.7M
13.18%301.54M
7.39%608.14M
11.06%266.42M
18.92%566.27M
23.54%239.89M
7.52%476.17M
-9.75%194.18M
279.60%442.88M
215.17M
Selling expenses
-16.27%-136.31M
-31.67%-60.57M
4.35%-117.24M
0.60%-46M
-15.98%-122.57M
-15.94%-46.28M
-9.38%-105.68M
-17.37%-39.92M
-730.71%-96.62M
---34.01M
Administrative expenses
-4.62%-159.98M
7.06%-71.93M
16.83%-152.92M
2.27%-77.4M
-27.59%-183.85M
7.70%-79.19M
-15.57%-144.09M
-106.66%-85.8M
-127.94%-124.68M
---41.52M
Revaluation surplus
-80.10%-20.63M
76.39%-1.65M
-182.30%-11.46M
-4,206.47%-6.98M
206.43%13.92M
-55.96%170K
--4.54M
--386K
----
----
-Changes in the fair value of financial assets
-80.10%-20.63M
76.39%-1.65M
-182.30%-11.46M
-4,206.47%-6.98M
206.43%13.92M
-55.96%170K
--4.54M
--386K
----
----
Operating interest expense
31.20%-21.04M
9.84%-10.74M
-49.74%-30.58M
-33.46%-11.91M
13.99%-20.42M
28.11%-8.93M
-205.05%-23.75M
-278.97%-12.42M
---7.78M
---3.28M
Special items of operating profit
322.58%27.29M
193.00%18.96M
-273.71%-12.26M
-242.79%-20.38M
-69.98%7.06M
108.35%14.28M
-70.98%23.52M
61.64%6.85M
1,271.98%81.05M
--4.24M
Operating profit
27.26%361.03M
69.26%175.61M
8.94%283.69M
-13.50%103.75M
12.87%260.41M
89.53%119.94M
-21.75%230.71M
-54.99%63.28M
578.94%294.85M
140.6M
Share of profits of associates
-3,501.41%-16.84M
-2,262.03%-12.13M
-27.53%495K
96.84%561K
6.39%683K
51.60%285K
-73.01%642K
-96.33%188K
-96.89%2.38M
--5.12M
Share of profit from joint venture company
-353.13%-5.82M
-206.94%-663K
-69.94%2.3M
-21,500.00%-216K
11,872.31%7.65M
---1K
---65K
----
----
----
Special items of earning before tax
135.56%958K
115.26%92K
-236.75%-2.69M
52.41%-603K
-219.58%-800K
59.36%-1.27M
329.90%669K
-101.61%-3.12M
87.54%-291K
--193.8M
Earning before tax
19.57%339.33M
57.41%162.91M
5.92%283.79M
-13.00%103.5M
15.51%267.94M
97.10%118.96M
-21.88%231.96M
-82.22%60.35M
152.45%296.94M
339.52M
Tax
-15.80%-102.2M
-74.31%-58.91M
16.89%-88.26M
18.76%-33.79M
-37.31%-106.19M
-71.46%-41.6M
-83.61%-77.34M
44.68%-24.26M
-132.53%-42.12M
---43.86M
After-tax profit from continuing operations
21.27%237.13M
49.21%104M
20.88%195.53M
-9.90%69.7M
4.61%161.75M
114.34%77.36M
-39.32%154.62M
-87.79%36.09M
156.08%254.82M
295.67M
Earning after tax
21.27%237.13M
49.21%104M
20.88%195.53M
-9.90%69.7M
4.61%161.75M
114.34%77.36M
-39.32%154.62M
-87.79%36.09M
156.08%254.82M
295.67M
Minority profit
92.83%-1.04M
108.67%993K
-13.12%-14.47M
-650.20%-11.45M
-211.98%-12.79M
30.29%-1.53M
79.68%-4.1M
22.84%-2.19M
-413.28%-20.18M
---2.84M
Profit attributable to shareholders
13.41%238.16M
26.94%103.01M
20.31%210M
2.87%81.15M
9.97%174.54M
106.07%78.89M
-42.28%158.72M
-87.18%38.28M
165.86%275M
298.5M
Basic earnings per share
12.88%0.1762
25.54%0.0762
18.35%0.1561
1.85%0.0607
10.56%0.1319
107.67%0.0596
-50.80%0.1193
-90.87%0.0287
44.78%0.2425
0.3145
Diluted earnings per share
13.68%0.1762
27.42%0.0762
19.78%0.155
1.70%0.0598
9.11%0.1294
105.59%0.0588
-44.79%0.1186
-90.91%0.0286
28.24%0.2148
0.3145
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Turnover 12.35%3.09B17.06%1.38B0.66%2.75B-0.86%1.18B12.46%2.73B20.95%1.19B4.09%2.43B7.50%981.24M463.96%2.33B--912.76M
Operating income 12.35%3.09B17.06%1.38B0.66%2.75B-0.86%1.18B12.46%2.73B20.95%1.19B4.09%2.43B7.50%981.24M463.96%2.33B912.76M
Cost of sales -12.89%-2.42B-18.20%-1.08B1.10%-2.14B3.88%-910.13M-10.88%-2.16B-20.31%-946.9M-3.29%-1.95B-12.82%-787.06M-536.39%-1.89B---697.6M
Operating expenses -12.89%-2.42B-18.20%-1.08B1.10%-2.14B3.88%-910.13M-10.88%-2.16B-20.31%-946.9M-3.29%-1.95B-12.82%-787.06M-536.39%-1.89B-697.6M
Gross profit 10.45%671.7M13.18%301.54M7.39%608.14M11.06%266.42M18.92%566.27M23.54%239.89M7.52%476.17M-9.75%194.18M279.60%442.88M215.17M
Selling expenses -16.27%-136.31M-31.67%-60.57M4.35%-117.24M0.60%-46M-15.98%-122.57M-15.94%-46.28M-9.38%-105.68M-17.37%-39.92M-730.71%-96.62M---34.01M
Administrative expenses -4.62%-159.98M7.06%-71.93M16.83%-152.92M2.27%-77.4M-27.59%-183.85M7.70%-79.19M-15.57%-144.09M-106.66%-85.8M-127.94%-124.68M---41.52M
Revaluation surplus -80.10%-20.63M76.39%-1.65M-182.30%-11.46M-4,206.47%-6.98M206.43%13.92M-55.96%170K--4.54M--386K--------
-Changes in the fair value of financial assets -80.10%-20.63M76.39%-1.65M-182.30%-11.46M-4,206.47%-6.98M206.43%13.92M-55.96%170K--4.54M--386K--------
Operating interest expense 31.20%-21.04M9.84%-10.74M-49.74%-30.58M-33.46%-11.91M13.99%-20.42M28.11%-8.93M-205.05%-23.75M-278.97%-12.42M---7.78M---3.28M
Special items of operating profit 322.58%27.29M193.00%18.96M-273.71%-12.26M-242.79%-20.38M-69.98%7.06M108.35%14.28M-70.98%23.52M61.64%6.85M1,271.98%81.05M--4.24M
Operating profit 27.26%361.03M69.26%175.61M8.94%283.69M-13.50%103.75M12.87%260.41M89.53%119.94M-21.75%230.71M-54.99%63.28M578.94%294.85M140.6M
Share of profits of associates -3,501.41%-16.84M-2,262.03%-12.13M-27.53%495K96.84%561K6.39%683K51.60%285K-73.01%642K-96.33%188K-96.89%2.38M--5.12M
Share of profit from joint venture company -353.13%-5.82M-206.94%-663K-69.94%2.3M-21,500.00%-216K11,872.31%7.65M---1K---65K------------
Special items of earning before tax 135.56%958K115.26%92K-236.75%-2.69M52.41%-603K-219.58%-800K59.36%-1.27M329.90%669K-101.61%-3.12M87.54%-291K--193.8M
Earning before tax 19.57%339.33M57.41%162.91M5.92%283.79M-13.00%103.5M15.51%267.94M97.10%118.96M-21.88%231.96M-82.22%60.35M152.45%296.94M339.52M
Tax -15.80%-102.2M-74.31%-58.91M16.89%-88.26M18.76%-33.79M-37.31%-106.19M-71.46%-41.6M-83.61%-77.34M44.68%-24.26M-132.53%-42.12M---43.86M
After-tax profit from continuing operations 21.27%237.13M49.21%104M20.88%195.53M-9.90%69.7M4.61%161.75M114.34%77.36M-39.32%154.62M-87.79%36.09M156.08%254.82M295.67M
Earning after tax 21.27%237.13M49.21%104M20.88%195.53M-9.90%69.7M4.61%161.75M114.34%77.36M-39.32%154.62M-87.79%36.09M156.08%254.82M295.67M
Minority profit 92.83%-1.04M108.67%993K-13.12%-14.47M-650.20%-11.45M-211.98%-12.79M30.29%-1.53M79.68%-4.1M22.84%-2.19M-413.28%-20.18M---2.84M
Profit attributable to shareholders 13.41%238.16M26.94%103.01M20.31%210M2.87%81.15M9.97%174.54M106.07%78.89M-42.28%158.72M-87.18%38.28M165.86%275M298.5M
Basic earnings per share 12.88%0.176225.54%0.076218.35%0.15611.85%0.060710.56%0.1319107.67%0.0596-50.80%0.1193-90.87%0.028744.78%0.24250.3145
Diluted earnings per share 13.68%0.176227.42%0.076219.78%0.1551.70%0.05989.11%0.1294105.59%0.0588-44.79%0.1186-90.91%0.028628.24%0.21480.3145
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg